8MW0511, a novel, long-acting granulocyte-colony stimulating factor fusion protein for the prevention of chemotherapy-induced neutropenia: final results from the phase III clinical trial.
Wang B, Chen X, Li H, Sun J, Jia X, Sun T, Yao Y, Wang J, Li J, Wang X, Wang X, Geng C, Ren Y, Yang L, Jia J, Chen Y, Li Z, Huang Y, Li B, Ren G, Chen J, Yu S, Mei J, Pei Z, Liu C, Cao X, Deng C, Huang M, Pan Y, Tu Y, Zhang Z, Luo R, Wang P, Dong J, Zhao H, Lu S, Zhu C, Cai S, Wang S, Hu X.
Wang B, et al. Among authors: dong j.
Breast Cancer Res. 2025 May 6;27(1):71. doi: 10.1186/s13058-025-02010-z.
Breast Cancer Res. 2025.
PMID: 40329331
Free PMC article.
Clinical Trial.